Lancet. 2022 Apr 1;S0140-6736(22)00456-1. doi: 10.1016/S0140-6736(22)00456-1. Online ahead of print.
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF)
: a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
Jonathan P Piccini, Valeria Caso, Stuart J Connolly, Keith A A Fox, Jonas Oldgren,
W Schuyler Jones, Diana A Gorog, Václav Durdil, Thomas Viethen, Christoph Neumann,
Hardi Mundl, Manesh R Patel, PACIFIC-AF Investigators
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF)
: a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
Jonathan P Piccini, Valeria Caso, Stuart J Connolly, Keith A A Fox, Jonas Oldgren,
W Schuyler Jones, Diana A Gorog, Václav Durdil, Thomas Viethen, Christoph Neumann,
Hardi Mundl, Manesh R Patel, PACIFIC-AF Investigators
アクセス
トータル
